{"name": "Del Mar Pharmaceuticals",
 "permalink": "del-mar-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/del-mar-pharmaceuticals",
 "homepage_url": "http://www.delmarpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "604-629-5989",
 "description": "",
 "created_at": "Fri Jun 14 10:55:39 UTC 2013",
 "updated_at": "Fri Jun 14 10:57:07 UTC 2013",
 "overview": "\u003Cp\u003EDelMar Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The company\u2019s principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. DelMar Pharmaceuticals, Inc. also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. The company was founded in 2010 and is headquartered in Vancouver, Canada.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       22],
      "assets/images/resized/0027/5261/275261v1-max-150x150.png"],
     [[250,
       37],
      "assets/images/resized/0027/5261/275261v1-max-250x250.png"],
     [[350,
       53],
      "assets/images/resized/0027/5261/275261v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO/cofounder",
    "person":
     {"first_name": "Jeffrey",
      "last_name": "Bacha",
      "permalink": "jeffrey-bacha",
      "image": null}},
   {"is_past": false,
    "title": "Chief Scientific Officer/cofounder \u0026 Director",
    "person":
     {"first_name": "Dennis",
      "last_name": "M. Brown",
      "permalink": "dennis-m-brown",
      "image": null}},
   {"is_past": false,
    "title": "Chief Financial Officer",
    "person":
     {"first_name": "Scott",
      "last_name": "Praill",
      "permalink": "scott-praill",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$10.5M",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1498382/000101376213000367/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 10500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 7,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "999 West Broadway",
    "address2": "Suite 720",
    "zip_code": "V5Z 1K5",
    "city": "Vancouver, BC and Redmond",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}